301103 何氏眼科
交易中 07-15 14:37:06
资讯
新帖
简况
何氏眼科:先进制造基金拟减持不超2%公司股份
格隆汇 · 06-30
何氏眼科:先进制造基金拟减持不超2%公司股份
【何氏眼科:股东先进制造基金拟减持2%】何氏眼科公告,持股5%以上股东先进制造产业投资基金计划自公告披露之日起十五个交易日后的三个月内,通过证券交易所集中竞价和大宗交易方式减持公司股份合计不超过310.61万股,占公司剔除回购专用证券账户中股份数量后的总股本比例的2%。
金融界 · 06-30
【何氏眼科:股东先进制造基金拟减持2%】何氏眼科公告,持股5%以上股东先进制造产业投资基金计划自公告披露之日起十五个交易日后的三个月内,通过证券交易所集中竞价和大宗交易方式减持公司股份合计不超过310.61万股,占公司剔除回购专用证券账户中股份数量后的总股本比例的2%。
何氏眼科收盘下跌3.29%,最新市净率1.87,总市值35.73亿元
金融界 · 06-10
何氏眼科收盘下跌3.29%,最新市净率1.87,总市值35.73亿元
每周股票复盘:何氏眼科(301103)每股派现15元,权益分派实施
证券之星 · 05-31
每周股票复盘:何氏眼科(301103)每股派现15元,权益分派实施
何氏眼科:并购标的必须与公司整体发展战略高度契合
证券之星 · 05-28
何氏眼科:并购标的必须与公司整体发展战略高度契合
何氏眼科:新院址设立需综合评估多方条件
证券之星 · 05-27
何氏眼科:新院址设立需综合评估多方条件
何氏眼科:2025年第一季度报告,营业收入为291,475,651.27元、同比增长2.35%
证券之星 · 05-26
何氏眼科:2025年第一季度报告,营业收入为291,475,651.27元、同比增长2.35%
何氏眼科收盘上涨1.02%,最新市净率1.72,总市值32.84亿元
金融界 · 05-16
何氏眼科收盘上涨1.02%,最新市净率1.72,总市值32.84亿元
何氏眼科:4月29日召开业绩说明会,投资者参与
证券之星 · 04-29
何氏眼科:4月29日召开业绩说明会,投资者参与
何氏眼科:脑机接口在眼科领域主要应用于视觉功能的评估、辅助诊断以及视力恢复等方面
证券之星 · 04-29
何氏眼科:脑机接口在眼科领域主要应用于视觉功能的评估、辅助诊断以及视力恢复等方面
图解何氏眼科一季报:第一季度单季净利润同比增12.27%
证券之星 · 04-24
图解何氏眼科一季报:第一季度单季净利润同比增12.27%
何氏眼科(301103.SZ)发布一季度业绩,归母净利润3253.19万元,增长12.27%
智通财经 · 04-24
何氏眼科(301103.SZ)发布一季度业绩,归母净利润3253.19万元,增长12.27%
何氏眼科:公司在2024年度进行过一轮股份回购详细情况见公司相关公告
证券之星 · 04-15
何氏眼科:公司在2024年度进行过一轮股份回购详细情况见公司相关公告
何氏眼科最新公告:副总经理卢山因达到法定退休年龄辞职
证券之星 · 03-10
何氏眼科最新公告:副总经理卢山因达到法定退休年龄辞职
何氏眼科跌1.06% 2022年上市募13亿中原证券保荐
中国经济网 · 03-06
何氏眼科跌1.06% 2022年上市募13亿中原证券保荐
何氏眼科:公司与豪雅、蔡司、依视路等多个眼镜品牌建立合作关系
证券之星 · 02-25
何氏眼科:公司与豪雅、蔡司、依视路等多个眼镜品牌建立合作关系
何氏眼科跌1.34% 2022年上市募13亿中原证券保荐
中国经济网 · 02-21
何氏眼科跌1.34% 2022年上市募13亿中原证券保荐
何氏眼科收盘上涨3.10%,最新市净率1.71,总市值33.11亿元
金融界 · 02-20
何氏眼科收盘上涨3.10%,最新市净率1.71,总市值33.11亿元
何氏眼科:基于AI技术中的深度学习算法实时监测并传输血糖级别至云端
证券之星 · 02-19
何氏眼科:基于AI技术中的深度学习算法实时监测并传输血糖级别至云端
加载更多
公司概况
公司名称:
辽宁何氏眼科医院集团股份有限公司
所属行业:
卫生
上市日期:
2022-03-22
主营业务:
辽宁何氏眼科医院集团股份有限公司的主营业务是为客户提供个性化、智慧化的眼健康管理服务。公司的主要产品是屈光不正手术矫正服务、白内障诊疗服务、玻璃体视网膜诊疗服务、其他眼病诊疗服务、非手术治疗、视光服务、其他业务收入。
发行价格:
42.50
{"stockData":{"symbol":"301103","market":"SZ","secType":"STK","nameCN":"何氏眼科","latestPrice":22.37,"timestamp":1752561426000,"preClose":22.64,"halted":0,"volume":1927130,"delay":0,"changeRate":-0.0119,"floatShares":83090100,"shares":158000000,"eps":-0.1509,"marketStatus":"交易中","change":-0.27,"latestTime":"07-15 14:37:06","open":22.63,"high":22.65,"low":22.09,"amount":43026200,"amplitude":0.0247,"askPrice":22.38,"askSize":5,"bidPrice":22.37,"bidSize":51,"shortable":0,"etf":0,"ttmEps":-0.1509,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1752562800000},"marketStatusCode":2,"adr":0,"adjPreClose":22.64,"symbolType":"stock","openAndCloseTimeList":[[1752543000000,1752550200000],[1752555600000,1752562800000]],"highLimit":24.9,"lowLimit":20.38,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":158026471,"isCdr":false,"pbRate":1.87,"roa":"--","roe":"1.72%","epsLYR":-0.1734,"committee":0.346154,"marketValue":3535000000,"turnoverRate":0.0232,"status":1,"floatMarketCap":1859000000},"requestUrl":"/m/hq/s/301103","defaultTab":"news","newsList":[{"id":"2547095776","title":"何氏眼科:先进制造基金拟减持不超2%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2547095776","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547095776?lang=zh_cn&edition=full","pubTime":"2025-06-30 19:28","pubTimestamp":1751282921,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["301103","BK0236","399260","161027"],"gpt_icon":0},{"id":"2547957840","title":"【何氏眼科:股东先进制造基金拟减持2%】何氏眼科公告,持股5%以上股东先进制造产业投资基金计划自公告披露之日起十五个交易日后的三个月内,通过证券交易所集中竞价和大宗交易方式减持公司股份合计不超过310.61万股,占公司剔除回购专用证券账户中股份数量后的总股本比例的2%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2547957840","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547957840?lang=zh_cn&edition=full","pubTime":"2025-06-30 19:25","pubTimestamp":1751282727,"startTime":"0","endTime":"0","summary":"何氏眼科公告,持股5%以上股东先进制造产业投资基金计划自公告披露之日起十五个交易日后的三个月内,通过证券交易所集中竞价和大宗交易方式减持公司股份合计不超过310.61万股,占公司剔除回购专用证券账户中股份数量后的总股本比例的2%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/30192551391407.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0236","301103","161027","399260"],"gpt_icon":0},{"id":"2542313537","title":"何氏眼科收盘下跌3.29%,最新市净率1.87,总市值35.73亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542313537","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542313537?lang=zh_cn&edition=full","pubTime":"2025-06-10 18:09","pubTimestamp":1749550191,"startTime":"0","endTime":"0","summary":"6月10日,何氏眼科今日收盘22.61元,下跌3.29%,最新市净率1.87,总市值35.73亿元。截至2025年一季报,共有8家机构持仓何氏眼科,其中其他7家、基金1家,合计持股数4082.31万股,持股市值8.07亿元。辽宁何氏眼科医院集团股份有限公司的主营业务是为客户提供个性化、智慧化的眼健康管理服务。最新一期业绩显示,2025年一季报,公司实现营业收入2.91亿元,同比2.35%;净利润3253.19万元,同比12.27%,销售毛利率43.80%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/10180950980201.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0236","301103"],"gpt_icon":0},{"id":"2539697785","title":"每周股票复盘:何氏眼科(301103)每股派现15元,权益分派实施","url":"https://stock-news.laohu8.com/highlight/detail?id=2539697785","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539697785?lang=zh_cn&edition=full","pubTime":"2025-05-31 18:18","pubTimestamp":1748686696,"startTime":"0","endTime":"0","summary":"截至2025年5月30日收盘,何氏眼科报收于21.04元,较上周的20.69元上涨1.69%。本周,何氏眼科5月30日盘中最高价报21.32元。本周关注点公司公告汇总:何氏眼科每股派现15元,权益分派实施公司公告汇总:中原证券对何氏眼科进行持续督导培训公司公告汇总何氏眼科发布2024年年度权益分派实施公告,具体内容如下:回购专用证券账户中的股份2722719股不参与本次权益分派。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025053100010947.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301103"],"gpt_icon":0},{"id":"2538798934","title":"何氏眼科:并购标的必须与公司整体发展战略高度契合","url":"https://stock-news.laohu8.com/highlight/detail?id=2538798934","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538798934?lang=zh_cn&edition=full","pubTime":"2025-05-28 20:51","pubTimestamp":1748436676,"startTime":"0","endTime":"0","summary":"证券之星消息,何氏眼科05月27日在投资者关系平台上答复投资者关心的问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052800035440.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301103","BK0236"],"gpt_icon":0},{"id":"2538469401","title":"何氏眼科:新院址设立需综合评估多方条件","url":"https://stock-news.laohu8.com/highlight/detail?id=2538469401","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538469401?lang=zh_cn&edition=full","pubTime":"2025-05-27 20:51","pubTimestamp":1748350273,"startTime":"0","endTime":"0","summary":"证券之星消息,何氏眼科05月26日在投资者关系平台上答复投资者关心的问题。公司总院沈阳何氏眼科医院坐落于沈阳北部,距离沈阳北站约9公里。目前,新院址的设立需综合评估区域医疗需求、政策支持、运营协同等多方条件,我司将结合整体发展战略审慎推进。同时,在沈阳南部区域,公司正在积极寻找合适的地点将新设医疗机构进行布局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052700035124.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301103"],"gpt_icon":0},{"id":"2538127364","title":"何氏眼科:2025年第一季度报告,营业收入为291,475,651.27元、同比增长2.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2538127364","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538127364?lang=zh_cn&edition=full","pubTime":"2025-05-26 15:09","pubTimestamp":1748243359,"startTime":"0","endTime":"0","summary":"证券之星消息,何氏眼科05月26日在投资者关系平台上答复投资者关心的问题。请如实告知何氏眼科回复:尊敬的投资者您好,截止目前公司最新披露的财务报告:2025年第一季度报告,营业收入为291,475,651.27元、同比增长2.35%,归属于上市公司股东净利润为32,531,877.20元,同比增长12.27%。公司正在按照既定的战略目标,积极开展各项业务,各项业务经营情况正常。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052600013816.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301103"],"gpt_icon":0},{"id":"2535255369","title":"何氏眼科收盘上涨1.02%,最新市净率1.72,总市值32.84亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535255369","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535255369?lang=zh_cn&edition=full","pubTime":"2025-05-16 17:41","pubTimestamp":1747388515,"startTime":"0","endTime":"0","summary":"5月16日,何氏眼科今日收盘20.78元,上涨1.02%,最新市净率1.72,创13天以来新低,总市值32.84亿元。股东方面,截至2025年3月31日,何氏眼科股东户数9399户,较上次减少392户,户均持股市值35.28万元,户均持股数量2.76万股。辽宁何氏眼科医院集团股份有限公司的主营业务是为客户提供个性化、智慧化的眼健康管理服务。最新一期业绩显示,2025年一季报,公司实现营业收入2.91亿元,同比2.35%;净利润3253.19万元,同比12.27%,销售毛利率43.80%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/16174150451690.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["301103","BK0236"],"gpt_icon":0},{"id":"2531665737","title":"何氏眼科:4月29日召开业绩说明会,投资者参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2531665737","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531665737?lang=zh_cn&edition=full","pubTime":"2025-04-29 21:31","pubTimestamp":1745933519,"startTime":"0","endTime":"0","summary":"证券之星消息,2025年4月29日何氏眼科发布公告称公司于2025年4月29日召开业绩说明会。公司将持续关注符合上述标准的优质标的,严格履行决策程序和信息披露义务,切实维护上市公司及全体股东权益。上述研发活动不断提升公司的诊疗效率和客户服务能力,有助于增强何氏的技术优势和服务壁垒、长期来看会增加公司的营业收入和利润。2024年公司毛利率变化受行业竞争加剧和医保支付方式变化等因素影响,总体有所下降。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042900042795.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301103","BK0236"],"gpt_icon":0},{"id":"2531739639","title":"何氏眼科:脑机接口在眼科领域主要应用于视觉功能的评估、辅助诊断以及视力恢复等方面","url":"https://stock-news.laohu8.com/highlight/detail?id=2531739639","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531739639?lang=zh_cn&edition=full","pubTime":"2025-04-29 20:51","pubTimestamp":1745931089,"startTime":"0","endTime":"0","summary":"证券之星消息,何氏眼科04月28日在投资者关系平台上答复投资者关心的问题。脑机接口通过直接连接大脑与外部设备的技术系统,为眼科医疗带来了全新的视角和可能性。目前,脑机接口在眼科领域主要应用于视觉功能的评估、辅助诊断以及视力恢复等方面。公司会密切关注相关技术的发展趋势,审慎评估未来布局机会。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042900039909.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301103","BK0236"],"gpt_icon":0},{"id":"2530096574","title":"图解何氏眼科一季报:第一季度单季净利润同比增12.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530096574","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530096574?lang=zh_cn&edition=full","pubTime":"2025-04-25 01:57","pubTimestamp":1745517426,"startTime":"0","endTime":"0","summary":"证券之星消息,何氏眼科2025年一季报显示,公司主营收入2.91亿元,同比上升2.35%;归母净利润3253.19万元,同比上升12.27%;扣非净利润3118.95万元,同比上升10.04%;负债率15.52%,投资收益133.96万元,财务费用-124.37万元,毛利率43.8%。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042500001225.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301103"],"gpt_icon":0},{"id":"2529677407","title":"何氏眼科(301103.SZ)发布一季度业绩,归母净利润3253.19万元,增长12.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529677407","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529677407?lang=zh_cn&edition=full","pubTime":"2025-04-24 17:40","pubTimestamp":1745487625,"startTime":"0","endTime":"0","summary":"智通财经APP讯,何氏眼科(301103.SZ)发布2025年第一季度报告,该公司营业收入为2.91亿元,同比增长2.35%。归属于上市公司股东的净利润为3253.19万元,同比增长12.27%。归属于上市公司股东的扣除非经常性损益的净利润为3118.95万元,同比增长10.04%。基本每股收益为0.2059元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1284045.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301103"],"gpt_icon":0},{"id":"2527104374","title":"何氏眼科:公司在2024年度进行过一轮股份回购详细情况见公司相关公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2527104374","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527104374?lang=zh_cn&edition=full","pubTime":"2025-04-15 20:51","pubTimestamp":1744721468,"startTime":"0","endTime":"0","summary":"证券之星消息,何氏眼科(301103)04月14日在投资者关系平台上答复投资者关心的问题。投资者提问:请问公司为何不相应号召,维护市值增持股份?谢谢何氏眼科回复:尊敬的投资者您好,公司在2024年度,进行过一轮股份回购,详细情况见公司相关公告。公司管理层高度关注国家关于资本市场健康发展的各项举措,同时公司根据市场情况及资金安排,积极探索运用多元化工具,稳步推进市值管理工作。若公司后续有实施股份回购的计划,将按规定及时履行信息披露义务。谢谢!以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025041500034935.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301103"],"gpt_icon":0},{"id":"2518264247","title":"何氏眼科最新公告:副总经理卢山因达到法定退休年龄辞职","url":"https://stock-news.laohu8.com/highlight/detail?id=2518264247","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518264247?lang=zh_cn&edition=full","pubTime":"2025-03-10 19:10","pubTimestamp":1741605037,"startTime":"0","endTime":"0","summary":"何氏眼科(301103.SZ)公告称,公司副总经理卢山因达到法定退休年龄,申请辞去公司副总经理职务,辞职后不再担任公司管理职务。卢山原定任期至第三届董事会届满之日止,截至公告披露日,卢山间接持有公司股份133,318股。辞职后,卢山将继续遵守相关股份减持规定。何氏眼科对卢山在担任公司高级管理人员期间的贡献表示感谢。以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025031000027574.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301103","BK0236"],"gpt_icon":0},{"id":"2517136800","title":"何氏眼科跌1.06% 2022年上市募13亿中原证券保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2517136800","media":"中国经济网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517136800?lang=zh_cn&edition=full","pubTime":"2025-03-06 16:28","pubTimestamp":1741249680,"startTime":"0","endTime":"0","summary":" 何氏眼科于2022年3月22日在深交所创业板上市,公开发行股票3050.00万股,发行价格为42.50元/股,保荐人为中原证券股份有限公司,保荐代表人为钟坚刚、封江涛。 何氏眼科首次公开发行股票的发行费用总额为13,193.87万元,其中,保荐承销费用9,990.49万元。 何氏眼科披露的2021年度分红派息、转增股本实施公告显示,公司于2022年5月19日召开的2021年年度股东大会审议通过了《关于2021年度利润分配及资本公积金转增股本预案的议案》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-03-06/doc-inentari6767991.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-03-06/doc-inentari6767991.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["601375","BK0201","301103","BK0276","BK0236"],"gpt_icon":0},{"id":"2514086907","title":"何氏眼科:公司与豪雅、蔡司、依视路等多个眼镜品牌建立合作关系","url":"https://stock-news.laohu8.com/highlight/detail?id=2514086907","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514086907?lang=zh_cn&edition=full","pubTime":"2025-02-25 09:00","pubTimestamp":1740445250,"startTime":"0","endTime":"0","summary":"证券之星消息,何氏眼科(301103)02月24日在投资者关系平台上答复投资者关心的问题。投资者:公司与哪些品牌的眼镜有合作或者销售?何氏眼科董秘:尊敬的投资者您好,公司与多个眼镜品牌建立合作关系,提供不同档次和功能的眼镜产品,以满足不同患者的需求。这些合作品牌包括不限于豪雅、蔡司、依视路以及公司推出的定制化昭晰镜片等品牌。感谢的您关注。以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022500008288.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301103","BK0236"],"gpt_icon":0},{"id":"2513254842","title":"何氏眼科跌1.34% 2022年上市募13亿中原证券保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2513254842","media":"中国经济网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513254842?lang=zh_cn&edition=full","pubTime":"2025-02-21 16:26","pubTimestamp":1740126360,"startTime":"0","endTime":"0","summary":" 何氏眼科于2022年3月22日在深交所创业板上市,公开发行股票3050.00万股,发行价格为42.50元/股,保荐人为中原证券股份有限公司,保荐代表人为钟坚刚、封江涛。 何氏眼科首次公开发行股票的发行费用总额为13,193.87万元,其中,保荐承销费用9,990.49万元。 何氏眼科披露的2021年度分红派息、转增股本实施公告显示,公司于2022年5月19日召开的2021年年度股东大会审议通过了《关于2021年度利润分配及资本公积金转增股本预案的议案》。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2025-02-21/doc-inemfscz2762936.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-02-21/doc-inemfscz2762936.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["601375","BK0276","BK0236","BK0201","301103"],"gpt_icon":0},{"id":"2512415639","title":"何氏眼科收盘上涨3.10%,最新市净率1.71,总市值33.11亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512415639","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512415639?lang=zh_cn&edition=full","pubTime":"2025-02-20 16:43","pubTimestamp":1740041024,"startTime":"0","endTime":"0","summary":"2月20日,何氏眼科今日收盘20.95元,上涨3.10%,最新市净率1.71,创33天以来新低,总市值33.11亿元。截至2024年三季报,共有1家机构持仓何氏眼科,其中基金1家,合计持股数460.00万股,持股市值0.93亿元。辽宁何氏眼科医院集团股份有限公司主营业务为面向眼病患者提供眼科专科诊疗服务和视光服务。沈阳何氏眼科医院被评为“国家临床重点专科”、国际眼科理事会眼科专科医师培训基地、国家药物临床试验机构。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/20164348280743.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["301103","BK0236"],"gpt_icon":0},{"id":"2512426331","title":"何氏眼科:基于AI技术中的深度学习算法实时监测并传输血糖级别至云端","url":"https://stock-news.laohu8.com/highlight/detail?id=2512426331","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512426331?lang=zh_cn&edition=full","pubTime":"2025-02-19 12:00","pubTimestamp":1739937632,"startTime":"0","endTime":"0","summary":"请详细介绍一下,谢谢何氏眼科董秘:尊敬的投资者您好,“何氏糖管家”基于AI技术中的深度学习算法,利用动态血糖监测设备,实时监测并传输血糖级别至云端,通过云端数据分析、医患交互平台及个性化健康管理方案,旨在实现糖尿病患者全生命周期的精准控糖与眼病防控。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021900017996.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301103"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1752561432346,"stockEarnings":[{"period":"1week","weight":0.0496},{"period":"1month","weight":0.0296},{"period":"3month","weight":0.2318},{"period":"6month","weight":0.2122},{"period":"1year","weight":0.0796},{"period":"ytd","weight":0.1332}],"compareEarnings":[{"period":"1week","weight":0.0134},{"period":"1month","weight":0.0422},{"period":"3month","weight":0.0771},{"period":"6month","weight":0.0906},{"period":"1year","weight":0.1846},{"period":"ytd","weight":0.0501}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"辽宁何氏眼科医院集团股份有限公司","boardCode":"AI0083","boardName":"卫生","stockholders":"9399人(较上一季度减少4.00%)","perCapita":"8840股","listingDate":"2022-03-22","address":"辽宁省沈阳市浑南区天赐街5-1号(607)","registeredCapital":"15802万元","survey":" 辽宁何氏眼科医院集团股份有限公司的主营业务是为客户提供个性化、智慧化的眼健康管理服务。公司的主要产品是屈光不正手术矫正服务、白内障诊疗服务、玻璃体视网膜诊疗服务、其他眼病诊疗服务、非手术治疗、视光服务、其他业务收入。","listedPrice":42.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"何氏眼科(301103)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供何氏眼科(301103)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"何氏眼科,301103,何氏眼科股票,何氏眼科股票老虎,何氏眼科股票老虎国际,何氏眼科行情,何氏眼科股票行情,何氏眼科股价,何氏眼科股市,何氏眼科股票价格,何氏眼科股票交易,何氏眼科股票购买,何氏眼科股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"何氏眼科(301103)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供何氏眼科(301103)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}